Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. J. Gomez-Reino

The Risk of Tuberculosis Related to Tumour Necrosis Factor Antagonist Therapies: A TBNET Consensus Statement

European Respiratory Journal

English

SAT0172 Long-Term Efficacy With 5-Year-Radiographic Results and Safety of Sarilumab in Combination With Csdmards in Patients With Rheumatoid Arthritis

2018

English

Related publications

LTBI: Latent Tuberculosis Infection or Lasting Immune Responses to M. Tuberculosis? A TBNET Consensus Statement

European Respiratory Journal

English

Pulmonary Granulomas After Tumour Necrosis Factor Alpha Antagonist Therapy

English

Reactivation of M. Tuberculosis Infection in Trans-Membrane Tumour Necrosis Factor Mice

PLoS ONE

Multidisciplinary

2011

English

The Use of the Tumour Necrosis Factor Antagonist Infliximab in Heart Transplant Recipients: Two Case Reports

Annals of the Rheumatic Diseases

English

E0154 Expression of Tumour Necrosis Factor- Converting Enzyme and Tumour Necrosis Factor- In Rats With Alcoholic Cardiomyopathy

Heart

Cardiovascular Medicine

Cardiology

2010

English

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated With Etanercept – A Tumour Necrosis Factor-Alpha Antagonist

Canadian Journal of Gastroenterology

2001

English

Crystallization and Preliminary X-Ray Analysis of the Tumour Necrosis Factor Α–tumour Necrosis Factor Receptor Type 2 Complex

Acta Crystallographica Section F Structural Biology and Crystallization Communications

2009

English

Systemic Cytotoxic and Biological Therapies of Colorectal Liver Metastases: Expert Consensus Statement

English

Circulating Tumour Necrosis Factor Alpha and Soluble Tumour Necrosis Factor Receptors in Patients With Different Patterns of Rheumatoid Synovitis

Annals of the Rheumatic Diseases

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by J. J. Gomez-Reino

The Risk of Tuberculosis Related to Tumour Necrosis Factor Antagonist Therapies: A TBNET Consensus Statement

SAT0172 Long-Term Efficacy With 5-Year-Radiographic Results and Safety of Sarilumab in Combination With Csdmards in Patients With Rheumatoid Arthritis

Related publications

LTBI: Latent Tuberculosis Infection or Lasting Immune Responses to M. Tuberculosis? A TBNET Consensus Statement

Pulmonary Granulomas After Tumour Necrosis Factor Alpha Antagonist Therapy

Reactivation of M. Tuberculosis Infection in Trans-Membrane Tumour Necrosis Factor Mice

The Use of the Tumour Necrosis Factor Antagonist Infliximab in Heart Transplant Recipients: Two Case Reports

E0154 Expression of Tumour Necrosis Factor- Converting Enzyme and Tumour Necrosis Factor- In Rats With Alcoholic Cardiomyopathy

Giant Cell Myocarditis in a Patient With Crohn's Disease, Treated With Etanercept – A Tumour Necrosis Factor-Alpha Antagonist

Crystallization and Preliminary X-Ray Analysis of the Tumour Necrosis Factor Α–tumour Necrosis Factor Receptor Type 2 Complex

Systemic Cytotoxic and Biological Therapies of Colorectal Liver Metastases: Expert Consensus Statement

Circulating Tumour Necrosis Factor Alpha and Soluble Tumour Necrosis Factor Receptors in Patients With Different Patterns of Rheumatoid Synovitis